Evidence map›Paper›PMID 25807250›Full record

ArticlePloS one2015

Random mutagenesis identifies a C-terminal region of YopD important for Yersinia type III secretion function.

Rebecca Solomon, Weibing Zhang, Grace McCrann, James B Bliska, Gloria I Viboud

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Rebecca SolomonClinical Laboratory Science, School of Health, Technology and Management, Stony Brook University, Stony Brook, New York, United States of America; Department of Molecular Genetics and Microbiology, Center for Infectious Diseases, School of Medicine, Stony Brook University, Stony Brook, New York, United States of America.
Weibing ZhangClinical Laboratory Science, School of Health, Technology and Management, Stony Brook University, Stony Brook, New York, United States of America; Department of Molecular Genetics and Microbiology, Center for Infectious Diseases, School of Medicine, Stony Brook University, Stony Brook, New York, United States of America.
Grace McCrannClinical Laboratory Science, School of Health, Technology and Management, Stony Brook University, Stony Brook, New York, United States of America.
James B BliskaDepartment of Molecular Genetics and Microbiology, Center for Infectious Diseases, School of Medicine, Stony Brook University, Stony Brook, New York, United States of America.
Gloria I ViboudClinical Laboratory Science, School of Health, Technology and Management, Stony Brook University, Stony Brook, New York, United States of America; Department of Molecular Genetics and Microbiology, Center for Infectious Diseases, School of Medicine, Stony Brook University, Stony Brook, New York, United States of America.
Stony Brook University · US

Funding

Regulation of host innate and adaptive immunity by bacterial type III effectorsR01AI099222 · NIAID · STATE UNIVERSITY NEW YORK STONY BROOK · PI BLISKA, JAMES B · 2012 to 2025
$5.9M
Regulation of Pore Formation by Type III Secretion SystemR21AI073815 · NIAID · STATE UNIVERSITY NEW YORK STONY BROOK · PI VIBOUD, GLORIA I · 2009 to 2010
$415k
NIAID NIH HHS R01 AI099222NIAID NIH HHS R01AI099222NIAID NIH HHS R21 AI073815NIAID NIH HHS R21-AI073815
6 · The paper itself

Abstract

A common virulence mechanism among bacterial pathogens is the use of specialized secretion systems that deliver virulence proteins through a translocation channel inserted in the host cell membrane. During Yersinia infection, the host recognizes the type III secretion system mounting a pro-inflammatory response. However, soon after they are translocated, the effectors efficiently counteract that response. In this study we sought to identify YopD residues responsible for type III secretion system function. Through random mutagenesis, we identified eight Y. pseudotuberculosis yopD mutants with single amino acid changes affecting various type III secretion functions. Three severely defective mutants had substitutions in residues encompassing a 35 amino acid region (residues 168-203) located between the transmembrane domain and the C-terminal putative coiled-coil region of YopD. These mutations did not affect regulation of the low calcium response or YopB-YopD interaction but markedly inhibited MAPK and NFκB. [corrected] activation. When some of these mutations were introduced into the native yopD gene, defects in effector translocation and pore formation were also observed. We conclude that this newly identified region is important for YopD translocon function. The role of this domain in vivo remains elusive, as amino acid substitutions in that region did not significantly affect virulence of Y. pseudotuberculosis in orogastrically-infected mice.

Indexed as

Amino Acid SubstitutionAnimalsBacterial Outer Membrane ProteinsCalciumCell LineCell SurvivalFemaleHeLa CellsHumansMiceMice, Inbred C57BLMitogen-Activated Protein Kinase KinasesNF-kappa BProtein Structure, TertiaryVirulenceYersinia pseudotuberculosisBacterial Outer Membrane ProteinsCalciumMitogen-Activated Protein Kinase KinasesNF-kappa BYopD protein, YersiniayopE protein, Yersinia

Identifiers

PMID25807250
PMCPMC4433470
OpenAlexW2078321260

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.